IQVIA Holdings Inc
(LTS:0JDM)
$
213.2157
-4.2843 (-1.97%)
Market Cap: 38.98 Bil
Enterprise Value: 51.15 Bil
PE Ratio: 29.71
PB Ratio: 6.25
GF Score: 91/100 - Q1 2024 IQVIA Holdings Inc Earnings Call TranscriptMay 02, 2024$224.44 (-3.19%)Earnings
- IQVIA Holdings Inc at Citigroup Inc Unplugged Medtech and Life Sciences Access Day TranscriptFeb 29, 2024
- Q4 2023 IQVIA Holdings Inc Earnings Call TranscriptFeb 14, 2024$238.36 (+11.09%)Earnings
- IQVIA Holdings Inc at Evercore ISI HealthCONx Conference TranscriptNov 29, 2023
- Q3 2023 IQVIA Holdings Inc Earnings Call TranscriptNov 01, 2023$178.53 (-1.13%)Earnings
- IQVIA Holdings Inc at Robert W Baird Global Healthcare Conference TranscriptSep 13, 2023
- IQVIA Holdings Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 IQVIA Holdings Inc Earnings Call TranscriptAug 01, 2023$220.68 (-1.55%)Earnings
- IQVIA Holdings Inc. - Special Call TranscriptMay 24, 2023
- Q1 2023 IQVIA Holdings Inc Earnings Call TranscriptApr 27, 2023$179.91 (-6.14%)Earnings
- IQVIA Holdings Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Q4 2022 IQVIA Holdings Inc Earnings Call TranscriptFeb 10, 2023$225.68 (-4.18%)Earnings
- IQVIA Holdings Inc Corporate Call TranscriptJan 18, 2023
- IQVIA Holdings Inc at Credit Suisse Healthcare Conference TranscriptNov 08, 2022
- Q3 2022 IQVIA Holdings Inc Earnings Call TranscriptOct 26, 2022$202.9 (+4.31%)Earnings
- IQVIA Holdings Inc at Robert W Baird Global Healthcare Conference TranscriptSep 14, 2022
- IQVIA Holdings Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Q2 2022 IQVIA Holdings Inc Earnings Call TranscriptJul 21, 2022$219 (+1.18%)Earnings
- IQVIA Holdings Inc at Jefferies Healthcare Conference TranscriptJun 10, 2022
- IQVIA Holdings Inc. - Special Call TranscriptMay 04, 2022
- Q1 2022 IQVIA Holdings Inc Earnings Call TranscriptApr 27, 2022$214.25 (+4.21%)Earnings
- IQVIA Holdings Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- IQVIA Holdings Inc at Citi Healthcare Conference (Virtual) TranscriptFeb 24, 2022
- Q4 2021 IQVIA Holdings Inc Earnings Call TranscriptFeb 15, 2022$226.7 (-5.02%)Earnings
- IQVIA Holdings Inc Analyst and Investor Conference (Virtual) TranscriptNov 16, 2021
- Q3 2021 IQVIA Holdings Inc Earnings Call TranscriptOct 21, 2021$243.5 (-3.62%)Earnings
- IQVIA Holdings Inc at Robert W Baird Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Q2 2021 IQVIA Holdings Inc Earnings Call TranscriptJul 27, 2021$249.18Earnings
- IQVIA Holdings Inc at William Blair Growth Stock Conference (Virtual) TranscriptJun 02, 2021
- Q1 2021 IQVIA Holdings Inc Earnings Call TranscriptApr 22, 2021$225.56 (+4.18%)Earnings
- IQVIA Holdings Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Q4 2020 IQVIA Holdings Inc Earnings Call TranscriptFeb 10, 2021$193.54 (+3.80%)Earnings
- Q3 2020 IQVIA Holdings Inc Earnings Call TranscriptOct 20, 2020$163.56Earnings
- Q2 2020 IQVIA Holdings Inc Earnings Call TranscriptJul 22, 2020$160 (+1.43%)Earnings
- Q1 2020 IQVIA Holdings Inc Earnings Call TranscriptApr 28, 2020$131.64Earnings
- Q4 2019 IQVIA Holdings Inc Earnings Call TranscriptFeb 12, 2020$159.76Earnings
- Q3 2019 IQVIA Holdings Inc Earnings Call TranscriptOct 30, 2019$147.45Earnings
- IQVIA Holdings Inc at Robert W Baird Global Healthcare Conference TranscriptSep 04, 2019
- Q2 2019 IQVIA Holdings Inc Earnings Call TranscriptJul 24, 2019$156.08Earnings
- IQVIA Holdings Inc Analyst and Investor Conference TranscriptJun 18, 2019
- IQVIA Holdings Inc at William Blair Growth Stock Conference TranscriptJun 05, 2019
- Q1 2019 IQVIA Holdings Inc Earnings Call TranscriptMay 01, 2019$137.38Earnings
- IQVIA Holdings Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mediterranean TranscriptApr 23, 2019
- IQVIA Holdings Inc at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Q4 2018 IQVIA Holdings Inc Earnings Call TranscriptFeb 14, 2019$131.66Earnings
IQVIA Holdings Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022 / 03:10PM GMT
Release Date Price:
$217.87
(-1.48%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst
Hey, everyone. Thanks for joining us. My name is Tejas Savant, and I'm the life science tools and diagnostics analyst at Morgan Stanley. It's my pleasure to host IQVIA this morning. And representing the company, we have Ron Bruehlman, CFO. So thanks, Ron, for doing this.
Ronald E. Bruehlman
IQVIA Holdings Inc. - Executive VP & CFO
You're very welcome.
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst
Before we get started, a quick disclaimer statement, please go to morganstanley.com/researchdisclosures. And if you have any questions, do reach out to your sales rep.
Questions & Answers
Tejas Rajeev Savant;Ronald E. Bruehlman
Morgan Stanley, Research Division - Equity Analyst
So perhaps, Ron, just to kick things off, can you just outline what you view as IQVIA's key accomplishments this year? And what are you most excited about as you look to 2023?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)